Advancing Erythroid Cell Biology (R01)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages investigator-initiated applications that propose hypothesis-driven research using erythroid cells.  The aim of this program is to support research efforts towards a complete description of the molecular and cellular components of erythropoiesis and how these components function to achieve normal erythropoiesis.  Components include genes that are expressed (transcriptome) in erythroid cells, either during development or during differentiation, chemical changes to DNA and histone proteins (epigenome) and the proteins (proteome) that are translated in erythroid cells, including post-translational modifications or subcellular localizations that are unique to erythroid cells.  A long range goal of this program is to generate a concise description of erythropoiesis that unifies genetics, molecular processes and cytokine determinants in the erythroid lineages so that new therapeutics may be developed to measure and combat anemia.

Deadlines:

  • R01 Deadlines: Feb. 5, Jun. 5, Oct. 5.
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7.

PA-16-039 Expiration Date: January 8, 2019

Eligibility

Faculty

Category

Environmental & Life Sciences
Medical
Medical - Basic Science
Medical - Clinical Science

External Deadline

October 5, 2018